Specify a stock or a cryptocurrency in the search bar to get a summary
GeneDx Holdings Corp.
WGSGeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. Address: North Tower, Stamford, CT, United States, 06902
Analytics
WallStreet Target Price
80.83 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures WGS
Dividend Analytics WGS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History WGS
Stock Valuation WGS
Financials WGS
Results | 2019 | Dynamics |